Derun Li

Title: Innovations of Derun Li in Antibiotic Synthesis

Introduction

Derun Li is an accomplished inventor based in Roselle Park, NJ (US). He has made significant contributions to the field of antibiotic synthesis, particularly focusing on the tetracycline class of antibiotics. With a total of 2 patents, his work has the potential to impact the treatment of infectious diseases.

Latest Patents

One of Derun Li's latest patents is centered on the "Synthesis of Tetracyclines and intermediates thereto." The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of tetracyclines in both human and veterinary medicine has led to resistance among many organisms that were previously susceptible to these antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs that have never been prepared before. This invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.

Career Highlights

Derun Li is associated with Harvard College, where he continues to advance his research in antibiotic synthesis. His innovative approaches have garnered attention in the scientific community, contributing to the ongoing fight against antibiotic resistance.

Collaborations

Some of his notable coworkers include Evan Hecker and Amelie Dion, who have collaborated with him on various projects related to antibiotic research.

Conclusion

Derun Li's work in the synthesis of tetracyclines represents a significant advancement in the field of antibiotics. His innovative methods and collaborations are paving the way for new treatments in the battle against infectious diseases.